A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 14,673 shares of OCGN stock, worth $13,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,673
Previous 14,560 0.78%
Holding current value
$13,352
Previous $22,000 36.36%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$0.98 - $1.95 $110 - $220
113 Added 0.78%
14,673 $14,000
Q2 2024

Jul 16, 2024

BUY
$1.18 - $1.98 $17,180 - $28,828
14,560 New
14,560 $22,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $197M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.